Search results for "Anticoagulants"
Diagnosing pulmonary embolism
Experts offer advice on how to apply the wide variety of available validated scores and algorithms, but also clinical judgment, to find pulmonary embolisms without excessive testing.
https://acphospitalist.acponline.org/archives/2022/02/23/free/diagnosing-pulmonary-embolism.htm
23 Feb 2022
Rule developed for starting DOACs after stroke in patients with atrial fibrillation
Using a “1-2-3-4-day rule” to choose when to start direct-acting oral anticoagulants (DOACs) based on stroke severity appeared to decrease risk for recurrent stroke or systemic embolism without increasing bleeding risk.
https://acphospitalist.acponline.org/archives/2022/02/09/rule-developed-for-starting-doacs-after-stroke-in-patients-with-atrial-fibrillation.htm
9 Feb 2022
Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients
An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/free/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022
NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant
The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/free/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022
Combating clots in COVID-19
Critical care experts advised on appropriate prophylaxis for ward and ICU patients as part of the CHEST 2021 conference.
https://acphospitalist.acponline.org/archives/2021/11/combating-clots-in-covid-19.htm
15 Nov 2021
Guidelines updated on use of antithrombotics for VTE
CHEST modified its 2016 recommendations on venous thromboembolism (VTE) management, with changes including the addition of cerebral vein thrombosis as a topic and strengthened support for outpatient VTE treatment.
https://acphospitalist.acponline.org/weekly/archives/2021/08/11/2.htm
11 Aug 2021
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/1.htm
16 Jun 2021
Diuretic guidance, endocarditis risks, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/06/recent-research.htm
15 Jun 2021
Three common, commonly missed poisons
Identify carbon monoxide, metformin, and salicylates when they strike.
https://acphospitalist.acponline.org/archives/2021/06/three-common-commonly-missed-poisons.htm
15 Jun 2021